Learn More
Cygnus Technologies CAP CELL LINE HCP ELISA KIT
Supplier: Cygnus Technologies F820
CAP Cell Line HCP ELISA Kit (F820)The CAP cell line, being of human origin, provides recombinant proteins with human-type glycosylation and is commonly employed in the production of recombinant proteins, gene therapy products, and vaccines. CAP cell line is a CEVEC Pharmaceuticals GmbH core proprietary technology. Our kit has been qualified for purification process and in-process lot release testing. This kit has an LOD of ~0.9 ng/ml.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.